Preparation method for alvimopan

A kind of technology of compound and intermediate, applied in the field of preparation of avimopan, can solve problems such as long steps and low yield, and achieve the effect of improving process and yield

Inactive Publication Date: 2011-03-16
万全万特制药江苏有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, the preparation method of alvimopan disclosed at home and abroad is: the compound (3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidine undergoes N-alkylation with methyl acrylate Reaction, further reaction with benzyl bromide, further hydrolysis to obtain compound II, the compound is then condensed with glycine isobutyl ester to obtain compound III, and then hydrolyzed to obtain alvimopan. This method has long steps and low yield , we changed the original 4-step reaction to 3 steps through the improvement of the route and got Alvimopan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for alvimopan
  • Preparation method for alvimopan
  • Preparation method for alvimopan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: (S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenyl Preparation of Propionic Acid (Compound II).

[0023]

[0024] Add 0.4g of Compound I, 4ml of hydrobromic acid, and 4ml of glacial acetic acid into a 50ml single-necked flask. The system turns into a yellow clear solution. Stir and heat to reflux. When heated to 60°C, the system turns lavender and reacts for 5h. TLC detected that the reaction was complete, the temperature dropped to room temperature, added 20ml of water, stirred, extracted with 50ml of ethyl acetate for 3 times, combined the organic phase, washed with 50ml of water for 3 times, dried the organic phase with anhydrous sodium sulfate, and suction filtered. The filtrate was evaporated under reduced pressure to obtain 0.3 g, yield: 88%.

[0025] MS (+1): 368.

[0026] 1 HNMR: δ (ppm, CDCl 3 ), 11.1(s, 1H), 7.21-7.01(m, 6H), 6.76(m, 1H), 6.85(m, 1H), 6.53(d, 1H), 5.0(s, 1H), 2.98-2.90( m, 3H), 2.76-2.41(m, 2H), ...

Embodiment 2

[0027] Example 2: 2-((S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3 - Preparation of ethyl amphetamine (amphetamino)acetate (compound III).

[0028]

[0029] Add 0.4g of compound II and 15ml of THF to a 25ml three-necked flask, protect it with nitrogen, stir and react for 1 hour, then add 10ml of the THF solution of 0.3g ethyl glycine, and react for 5 hours. TLC shows that the raw materials have basically reacted, and add 30ml of water, 50ml of ethyl acetate*3 times of extraction, the organic phase was rotary evaporated under reduced pressure to obtain 0.4g of a muddy yellow viscous liquid with a yield of 81%.

[0030] MS (+1): 453

[0031] 1 HNMR: δ (ppm, CDCl 3 ), 7.21-7.01(m, 6H), 6.85(d, 1H), 6.76(s, 1H), 6.53(d, 1H), 5.0(s, 1H), 4.12(m, 2H), 3.51(s, 2H), 2.63-2.38(m, 4H), 2.44-2.04(m, 8H), 2.0(m, 1H), 1.88-1.63(m, 2H), 1.44(s, 3H), 1.30(t, 3H) , 1.06 (d, 3H).

Embodiment 3

[0032] Example 3: 2-((S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl) dihydrate - Preparation of 3-phenylpropanoic acid amino) acetic acid (almovepam)

[0033]

[0034] Add 0.8g of compound IV, 16.5ml of absolute ethanol: water (4.5:1) into a 50ml single-necked bottle, stir, add 6.5ml of 1mol / L NaOH solution, and react at room temperature 25°C for 2h. Adjust the pH to 6 with concentrated hydrochloric acid, stir for 2 hours, remove the ethanol by rotary evaporation under reduced pressure, extract with 50ml*3 times of chloroform, combine the organic phases, and obtain 0.4g brown viscous liquid after rotary evaporation under reduced pressure, with a yield of 53%. Impurity needs to be purified by column chromatography.

[0035] MS (+1): 425.

[0036] 1 HNMR: δ (ppm, CDCl 3), 11.0(s, 1H), 8(m, 1H), 7.21-7.01(m, 6H), 6.85(d, 1H), 6.76(s, 1H), 6.53(d, 1H), 5.0(s, 1H), 4.14(s, 2H), 3.05(m, 1H), 2.91-2.66(m, 2H), 2.47(d, 2H), 2.33-2.04(m, 5H), 1.88-1.63(m,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method for alvimopan, which comprises the following steps: (1) in organic solvent, a compound I is subject to deprotection and hydrolysis reaction in the presence of acid to obtain a componed II; (2) the compound II and glycine esters are subject to condensation reaction to obtain a compound III; and (3) the compound III is subject to ester hydrolysis to obtain the alvimopan. The invention provides a novel synthesis method for the alvimopan, which reduces the steps of the original preparation route, reduces the cost and improves the yield of the alvimopan.

Description

technical field [0001] The invention relates to a preparation method of alvimopan. Background technique [0002] Alvimopan, chemical name (+)-2-[2(S)-benzyl-3-[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl piperidin-1-yl]propionamido]acetic acid. The drug was jointly developed by GlaxoSmithKline and Adolor, and Alvimopan (alvimopan, ADL-8-2698, LY-246736) was approved by the US Food and Drug Administration on May 20, 2008. The Food and Drug Administration (FDA) approved the listing for surgery and other gastrointestinal disorders caused by the use of opioids to speed up the recovery of gastrointestinal function and shorten the length of hospital stay. The trade name is Entereg. Alvimopan is a new type of peripheral μ-type opioid receptor antagonist (opioid and opioid receptors play an important role in regulating gastrointestinal function), and it is clinically used for surgery and the use of opioids. Gastrointestinal disorders, idiopathic constipation and irritable bowel syndro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D211/22
Inventor翟富民邓平
Owner万全万特制药江苏有限公司